Variant report
Variant | esv3373059 |
---|---|
Chromosome Location | chr7:126897516-126901714 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:21)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:21 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr7:126898150-126898361 | K562 | blood: | n/a | n/a |
2 | CTCF | chr7:126898300-126898450 | K562 | blood: | n/a | n/a |
3 | CTCF | chr7:126899513-126899840 | GM19239 | blood: | n/a | n/a |
4 | CTCF | chr7:126898292-126898512 | K562 | blood: | n/a | n/a |
5 | JUND | chr7:126898151-126898476 | K562 | blood: | n/a | chr7:126898295-126898303 chr7:126898295-126898302 chr7:126898296-126898307 chr7:126898295-126898303 |
6 | MYC | chr7:126899453-126899703 | MCF-7 | breast: | n/a | n/a |
7 | MYC | chr7:126899418-126899425 | MCF-7 | breast: | n/a | n/a |
8 | MYC | chr7:126899399-126899410 | MCF-7 | breast: | n/a | n/a |
9 | MYC | chr7:126899707-126899743 | MCF-7 | breast: | n/a | n/a |
10 | MYC | chr7:126899427-126899446 | MCF-7 | breast: | n/a | n/a |
11 | MYC | chr7:126899476-126899688 | MCF-7 | breast: | n/a | n/a |
12 | MYC | chr7:126899706-126899751 | MCF-7 | breast: | n/a | n/a |
13 | MYC | chr7:126899413-126899417 | MCF-7 | breast: | n/a | n/a |
14 | POLR2A | chr7:126899421-126899717 | Gliobla | brain: | n/a | n/a |
15 | RAD21 | chr7:126898288-126898568 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | RCOR1 | chr7:126898226-126898468 | K562 | blood: | n/a | n/a |
17 | RCOR1 | chr7:126901146-126901186 | K562 | blood: | n/a | n/a |
18 | TAL1 | chr7:126901055-126901124 | K562 | blood: | n/a | n/a |
19 | TBP | chr7:126898295-126898357 | K562 | blood: | n/a | n/a |
20 | ZNF143 | chr7:126898328-126898455 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | ZNF263 | chr7:126898133-126898529 | HEK293-T-REx | kidney: | n/a | chr7:126898325-126898346 |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
GRM8 | TF binding region |
ENSG00000179603 | chromatin interactions |
ENSG00000048405 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557072975 | chr7:126897532-126897533 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs17868493 | chr7:126897553-126897554 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs541472092 | chr7:126897563-126897564 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs543632189 | chr7:126897573-126897574 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs565006908 | chr7:126897578-126897579 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs532454251 | chr7:126897620-126897621 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs532064068 | chr7:126897629-126897630 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs540989906 | chr7:126897644-126897645 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs17868410 | chr7:126897693-126897694 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs374336926 | chr7:126897743-126897744 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs17870072 | chr7:126897763-126897764 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs561639182 | chr7:126897770-126897771 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs145819115 | chr7:126897811-126897812 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs548293983 | chr7:126897840-126897841 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs529025976 | chr7:126897848-126897849 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs17862335 | chr7:126897887-126897888 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs530988457 | chr7:126897924-126897925 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs13243651 | chr7:126897929-126897930 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs140661849 | chr7:126897945-126897946 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs571021574 | chr7:126897951-126897952 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs534994529 | chr7:126898007-126898008 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs17865366 | chr7:126898011-126898012 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs376451452 | chr7:126898072-126898073 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs145374827 | chr7:126898084-126898085 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs79000069 | chr7:126898104-126898105 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs568104354 | chr7:126898136-126898137 | Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs563126325 | chr7:126898151-126898152 | Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs17862336 | chr7:126898189-126898190 | Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs17868409 | chr7:126898231-126898232 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs557013703 | chr7:126898374-126898375 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs575715790 | chr7:126898375-126898376 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs570266432 | chr7:126898380-126898381 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs543219258 | chr7:126898388-126898389 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs558728714 | chr7:126898419-126898420 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs577020136 | chr7:126898439-126898440 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs36013614 | chr7:126898500-126898501 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs541332577 | chr7:126898511-126898512 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs80029727 | chr7:126898519-126898520 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs57172153 | chr7:126898520-126898521 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs577316634 | chr7:126898521-126898522 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs373763947 | chr7:126898554-126898555 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs533516196 | chr7:126898591-126898592 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs137927001 | chr7:126898592-126898593 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs529696698 | chr7:126898599-126898600 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs541872675 | chr7:126898600-126898601 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs17862337 | chr7:126898623-126898624 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs187947468 | chr7:126898669-126898670 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs375539441 | chr7:126898736-126898737 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs372870617 | chr7:126898798-126898799 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs552453798 | chr7:126898801-126898802 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Autism | 20808228 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
Prostate cancer | 17217626 | CNVD |
Coffin-Siris syndrome | 21572526 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:126894200-126897600 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
2 | chr7:126894200-126902800 | Weak transcription | Right Atrium | heart |
3 | chr7:126894600-126899600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr7:126895800-126897800 | Enhancers | Fetal Brain Male | brain |
5 | chr7:126897400-126898000 | Enhancers | Fetal Brain Female | brain |
6 | chr7:126897600-126898000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr7:126897800-126898200 | Bivalent Enhancer | Fetal Brain Male | brain |
8 | chr7:126898200-126898800 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
9 | chr7:126899000-126899400 | Weak transcription | Pancreas | Pancrea |
10 | chr7:126899400-126899800 | ZNF genes & repeats | H9 Cell Line | embryonic stem cell |
11 | chr7:126899600-126903000 | Weak transcription | Pancreas | Pancrea |
12 | chr7:126899600-126904600 | Weak transcription | Gastric | stomach |